Market narrative
Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.
The average of price targets set by Wall Street analysts indicates a potential upside of 29.8% in Sony (SONY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Stocks
Atlanta Braves Holdings, Inc. (BATRA) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of $0.42. This compares to earnings of $0.46 per share a year ago.
Atlanta Braves Holdings (BATRK) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of $0.31. This compares to earnings of $0.46 per share a year ago.
CNH Industrial N.V. (CNH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support.
The average of price targets set by Wall Street analysts indicates a potential upside of 25.7% in Cushman & Wakefield (CWK). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
fuboTV Inc. (FUBO) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.07. This compares to earnings of $0.6 per share a year ago.
The average of price targets set by Wall Street analysts indicates a potential upside of 144% in Dakota Gold Corp. (DC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The average of price targets set by Wall Street analysts indicates a potential upside of 32% in Boot Barn (BOOT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Global Ship Lease (GSL) came out with quarterly earnings of $2.48 per share, beating the Zacks Consensus Estimate of $2.34 per share. This compares to earnings of $2.67 per share a year ago.
The average of price targets set by Wall Street analysts indicates a potential upside of 25.1% in Napco (NSSC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
NewAmsterdam Pharma Company N.V. (NAMS) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.48.
The average of price targets set by Wall Street analysts indicates a potential upside of 30.9% in Methanex (MEOH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
NNN REIT (NNN) came out with quarterly funds from operations (FFO) of $0.9 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to FFO of $0.85 per share a year ago.
One Stop Systems, Inc. (OSS) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.07 per share a year ago.
The mean of analysts' price targets for Redwire Corporation (RDW) points to a 40% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Southwest Gas (SWX) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.53 per share a year ago.
Trinity Capital (TRIN) came out with quarterly earnings of $0.51 per share, missing the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.53 per share a year ago.
Orion Energy Systems, Inc. (OESX) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to a loss of $0.4 per share a year ago.
Urogen Pharma (URGN) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to a loss of $1.05 per share a year ago.
OceanaGold receives a Strong Buy rating, driven by robust operational improvements and a compelling valuation discount to peers. OGC's diversified portfolio and aggressive buyback program underpin strong projected FCF into the 2030s. Operational upgrades at Haile and Macraes, plus fast-track approval for Waihi North, position OGC for significant production and earnings growth.
